This post was contributed by Ezequiel Silva III, FACR, MD, chair of the ACR Commission on Economics and practicing interventional radiologist in San Antonio, TX.
It seems pretty much everywhere you look lately, experts and investors are predicting that interventional radiology (IR) is set for rapid growth. Now we just have to work to ensure that there will be enough clinical interventional radiology practices (and interventional radiologists) to meet the increase demand. The American College of Radiology (ACR) and Society for Interventional Radiology (SIR) are taking steps to help IRs meet that need head-on.
The ACR and SIR created downloadable resources — including the “IR C-Suite Toolkit” to help IRs educate hospital executives, radiology group officers and other decision makers on the clinical and economic benefits of starting a full-fledged, in-house IR practice.
Available at acr.org/IR, the toolkit helps IRs explain:
- How IR can help health system executives achieve the health care “triple aim”
- That IR improves clinical outcomes, recovery times and patient satisfaction — key factors in new delivery and payment models
- How clinical IR enables health systems to maximize reimbursement in care models that reward facilities for making and keeping patients well instead of payment based on procedural volumes
- The increasingly valuable role interventional oncology serves in cancer treatment, particularly as the federal government’s Cancer Moonshot effort evolves.
IRs must tell their powerful story of lower costs, less invasive treatment and quicker recovery times. These are primary aims of ongoing health care reform. The audience is there. We just have to take the information to them.
- Have you had a conversation with your hospital administrators about starting a clinical IR practice?
- If so — what tips might you have for other IRs?
- Which metrics did you find particularly effective?
Please share your thoughts in the comments section below and/or join the discussion on Engage (login required).